Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1248-1252

  Touitou, Y ^a   Bogdan, A ^a   Levi F ^b   Benavides, M ^b   Auzeby A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Breast cancer; CA 125; CA 15 3; Carcinoembryonic antigen; Cortisol circadian rhythm; Ovarian cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HYDROCORTISONE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; CANCER PATIENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; OVARY CANCER; PRIORITY JOURNAL;

EID: 0029842405     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.524     Document Type: Article

References (20)

1. DUNN AJ. (1990). Interleukin-1 as a stimulator of hormone secretion. P.N.E.I., 3, 26 - 34.
2. FOCAN C, FOCAN-HENRARD D, COLETTE J, MECHKOURI M, LÉVI F, HRUSHESKY WJ, TOUITOU Y AND FRANCHIMONT P. (1986a). Cancer-associated alteration of circadian rhythms in carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) in humans. Anticancer Res., 6, 1137-1144.
3. FOCAN C, FOCAN-HENRARD D, FRÈRE MH, LE HUNG S, CASTRONOVO V, COLLETTE J, FRANCHIMONT P. TOUITOU Y. LÉVI F, V ROEMELING RW AND HRUSHESKY WJ. (1986b). Circadian CEA variability: when to sample? J. Clin. Oncol., 4, 607 - 608.
4. FOLLENIUS M, SIMON C, BRANDENBERGER G AND LENZI P. (1982). Diurnal cortisol peaks and their relation to meals. J. Clin. Endocrinol. Metab., 55, 757-761.
5. GATTI G, ANGELI A AND CARIGNOLA R. (1994). Chronobiology of endocrine-immune interactions. In Biologic Rhythms in Clinical and Laboratory Medicine, Touitou Y and Haus E. (eds) pp. 363-374, Springer Verlag: Paris.
6. GAUTHERIE M AND GROS C. (1977). Circadian rhythm alteration of skin temperature in breast cancer. Chronobiologia, 4, 1-17.
7. GENNAZZANI AR, PETRAGLIA F, NAPPI C, MARTIGNONI E, DE LEO M AND FACCHINETI F. (1983). Endorphins in peripheral plasma: origin and influencing factors. In Central and Peripheral Endorphins: Basic and Clinical Aspects, Muller EE and Gennazzani AR. (eds) pp. 89-87. Raven Press: New York.
8. HAUS E AND TOUITOU Y. (1994). Chronobiology in laboratory medicine. In Biologic Rythms in Clinical and Laboratory Medicine, Touitou Y and Haus E. (eds) pp. 673-708. Springer Verlag: Paris.
9. KLEVECZ R. SHYMKO R AND BRALY P. (1987). Circadian gating of S phase in human ovarian cancer. Cancer Res., 47, 6267 - 6271.
10. KRIPKE DF, DRENNAN MD AND ELLIOTT JA. (1994). The complex circadian pacemaker in affective disorders. In Biologic Rhythms in Clinical and Laboratory Medicine, Touitou Y and Haus E. (eds) pp. 265-276. Springer Verlag: Paris.
11. QUIGLEY ME AND YEN SSC. (1979). A mid-day surge in cortisol levels. J. Clin. Endocrinol. Metab., 49, 945-947.
12. REINBERG A AND SMOLENSK Y M. (1983). Biological Rhythms and Medicine. Cellular, Metabolic, Physiopathologic and Pharmacologic Aspects, Springer Verlag: Paris.
13. SALAS MA, EVANS SW, LEVELL MJ AND WHICHER JT. (1990). Interleukin-6 and ACTH act synergistically to stimulate adrenal cell glands. Clin. Exp. Immunol., 79, 470-473.
14. TOUITOU Y AND BOGDAN A. (1988). Tumor markers in non-malignant diseases. Eur. J. Cancer Clin. Oncol., 42, 1083-1096.
15. TOUITOU Y AND HAUS E. (1994). Biologic Rhythms in Clinical and Laboratory Medicine. Springer Verlag: Paris.
16. TOUITOU Y, SULON J, BOGDAN A, TOUITOU C, REINBERG A, BECK H, SODOYEZ JC AND VAN CAUWENBERGE H. (1982). Adrenal cireadian system in young and elderly human subjects: a comparative study. J. Endocrinol., 93, 201-210.
17. TOUITOU Y, SULON J, BOGDAN A, REINBERG A, SODOYEZ JC AND DEMEY-PONSART E. (1983). Adrenocortical hormones, ageing and mental condition: seasonal and circadian rhythms of plasma 18-hydroxy-1 I-deoxycorticosterone. total and free cortisol and urinary corticosteroids. J. Endocrinol., 96, 53-64.
18. TOUITOU Y, SOTHERN RB, LÉVI F, FOCAN C, BOGDAN A, AUZÉBY A, FRANCHIMONT P, VON ROEMELING RW AND HRUSHESKY WJ. (1988). Sources of predictable tumor marker variation within the so called normal range: circadian and circannual aspects of plasma carcinoembryonic antigen (CEA) in health and disease. J. Tumor Marker Oncol., 3, 351-359.
19. TOUITOU Y, LÉVI F, BOGDAN A, BENAVIDES M, BAILLEUL F AND MISSET JL. (1995). Rhythm alterations in patients with melaslatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol., 121, 181-188.
20. VOUTILAINEN A. (1953). Über die 24 Studen Rhythmik der Mitofrequenz in malignen Tumoren. Acta Path. Microb. Scand. (suppl.), 99, 1-104.